AMG 199
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 199, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers [Phase 1]